Depletion of antioxidants is associated with no-reflow phenomenon in acute myocardial infarction

Clinical Cardiology

Volumn 27, Issue 8, 2004, Pages 466-470

  Matsumoto, Hidenari ^a   Inoue, Nobutaka ^a   Takaoka, Hideyuki ^a   Hata, Katsuya ^a   Shinke, Toshiro ^a   Yoshikawa, Ryohei ^a   Masai, Hiroyuki ^a   Watanabe, Satoshi ^a   Ozawa, Toru ^a   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary circulation; Oxidative stress; Percutaneous coronary intervention; Reperfusion

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CATALASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; FEMALE; HUMAN; MALE; OXIDATION REDUCTION STATE; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; VITAMIN BLOOD LEVEL;

EID: 3242886664     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960270809     Document Type: Article

References (17)

1. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T: Clinical implications of "no-reflow" phenomenon: A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228
2. Garlick PB, Davies MJ, Hearse DJ, Slater TF: Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987;61:757-760
3. The TIMI Study Group: The Thrombolysis In Myocardial Infarction (TIMI) trial. N Engl J Med 1985;31:932-936
4. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E: TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888
5. Reffelmann T, Kloner RA: No-reflow phenomenon. Circulation 2002;105:656-662
6. Ferrari R, Ceconi C, Curello S, Guarnieri C, Caldarera CM, Albertini A, Visioli O: Oxygen-mediated myocardial damage during ischemia and reperfusion: Role of the cellular defenses against oxygen toxicity. J Moll Cell Cardiol 1985;17:935-945
7. Pandey NR, Kaur G, Chandra M, Sanwal GG, Misra MK: Enzymatic oxidant and antioxidants of human blood platelets in unstable angina and myocardial infarction. Int J Cardiol 2000;76:33-38
8. Yoshida T, Maulik N, Engelman RM, Ho YS, Magnenat JL, Rousou JA, Flack JE III, Deaton D, Das DK: Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation 1997;96(suppl II):216-220
9. Yoshida T, Watanabe M, Engelman DT, Engelman RM, Schley JA, Maulik N, Ho YS, Oberley TD, Das DK: Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J Moll Cell Cardiol 1996;28:1759-1767
10. Sebbag L, Forrat R, Canet E, Renaud S, Delaye J, de Lorgeril M: Effects of dietary supplementation with alpha-tocopherol on myocardial infarct size and ventricular arrhythmias in a dog model of ischemia-reperfusion. J Am Coll Cadiol 1994;24:1580-1585
11. Campo GM, Squadrito F, Campo S, Altavilla D, Quartarone C, Ceccarelli S, Ferlito M, Avenoso A, Squadrito G, Saitta A, Caputi AP: Beneficial effect of raxofelast, a hydrophilic vitamin E analogue, in the rat heart after ischemia and reperfusion injury. J Moll Cell Cardiol 1998;30:1493-1503
12. Carrasquedo F, Glanc M, Fraga CG: Tissue damage in acute myocardial infarction: Selective protection by vitamin E. Free Radic Biol Med 1999;26:1587-1590
13. Morishima I, Sone T, Mokuno S, Taga S, Shimauchi A, Oki Y, Kondo J, Tsuboi H, Sassa H: Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal angioplasty. Am Heart J 1995;130:239-243
14. Iwakura K, Ito H, Takiuchi S, Taniyama Y, Nakatsuchi Y, Negoro S, Higashino Y, Okamura A, Masuyama T, Hori M, Fujii K, Minamino T: Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation 1996;94:1269-1275
15. Kondo M, Nakano A, Saito D, Shimono Y: Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction. J Am Coll Cardiol 1998;32:898-903
16. Gibson CM, Murphy SA, Rizzo MJ, Ryan KA, Marble SJ, McCabe CH, Cannon CP, Van de Werf F, Braunwald E: Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation 1999;99:1945-1950
17. Hamada S, Nishiue T, Nakamura S, Nakamura S, Sugiura T, Kamihata H, Miyoshi H, Imuro Y, Iwasaka T: TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction. J Am Coll Cardiol 2001;38:666-671